BDD has proven expertise in early phase clinical research and has supported the pharmaceutical industry in understanding in vivo product performance for over 20 years with bespoke clinical services.
We recognise the complexities of drug development and have created an integrated clinical and manufacturing service to enable rapid in vivo evaluation of new products saving our clients considerable time and expense during product development.
At BDD we focus on low volume, high value studies which utilise clinical tools such as Gamma Scintigraphy and SWIFT adaptive clinical studies to provide our clients with clear answers to how their drug delivery systems perform in vivo.
As every product is unique, we always work collaboratively with our clients throughout the lifecycle of a project to ensure we deliver high quality data using a scientifically led approach.
Our early phase clinical services can be tailored to suit Sponsor requirements from simply acting as a clinical site to providing a full CRO Service including:
BDD has an independent clinical facility located in Glasgow, Scotland. Established in 2001 within the Glasgow Royal Infirmary hospital, the facility offers a gamma camera imaging suite, laboratory, consulting rooms, recreational areas, and an in-patient ward area for clinical monitoring and overnight visits.
The facility includes an integrated MHRA accredited GMP manufacturing suite enabling IMPs to be manufactured and QP released onsite for dosing to trial participants on the same day.